Linde M Braaf

Affiliations

Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publications (1)

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Nature medicine

Avec: Jeroen van Dorp , Christodoulos Pipinikas , Britt B M Suelmann , Niven Mehra , Nick van Dijk , Giovanni Marsico , Maurits L van Montfoort , Sophie Hackinger , Linde M Braaf , Tauanne Amarante , Charlaine van Steenis , Kirsten McLay , Antonios Daletzakis , Daan van den Broek , Maaike W van de Kamp , Kees Hendricksen , Jeantine M de Feijter , Thierry N Boellaard , Richard P Meijer , Antoine G van der Heijden , Nitzan Rosenfeld , Bas W G van Rhijn , Greg Jones , Michiel S van der Heijden

Réseau de co-auteurs

Jeroen van Dorp 1 collaboration

Christodoulos Pipinikas 1 collaboration

Britt B M Suelmann 1 collaboration

Niven Mehra 1 collaboration

Nick van Dijk 1 collaboration

Giovanni Marsico 1 collaboration

Maurits L van Montfoort 1 collaboration

Sophie Hackinger 1 collaboration

Tauanne Amarante 1 collaboration

Charlaine van Steenis 1 collaboration

Kirsten McLay 1 collaboration

Antonios Daletzakis 1 collaboration

Daan van den Broek 1 collaboration

Maaike W van de Kamp 1 collaboration

Kees Hendricksen 1 collaboration

Jeantine M de Feijter 1 collaboration

Thierry N Boellaard 1 collaboration

Richard P Meijer 1 collaboration

Antoine G van der Heijden 1 collaboration

Nitzan Rosenfeld 1 collaboration

Bas W G van Rhijn 1 collaboration

Greg Jones 1 collaboration

Michiel S van der Heijden 1 collaboration